Advertisement

Myasthenia Gravis

  • Daniel J. Sisti
Chapter

Abstract

A case of an emergency surgery in a 74-year-old man with free air in the abdomen highlights anesthetic challenges in the management of patients with myasthenia gravis. The underlying pathophysiology of myasthenia gravis is typically an autoimmune-mediated destruction of acetylcholine receptors in the neuromuscular junction, resulting in easy fatigability and weakness. The diagnosis of myasthenia gravis is established via electromyography studies and the identification of antibodies specific to myasthenia gravis. Medical treatment of myasthenia gravis involves steroids, immune modulators, plasmapheresis, and symptomatic treatment with acetylcholinesterase inhibitors. Many patients can achieve long-term cure with surgical thymectomy. Patients with myasthenia gravis present an anesthetic challenge because they can have other comorbid autoimmune diseases, compromised respiratory status, and atypical reactions to neuromuscular blockade, with resistance to succinylcholine and exquisite sensitivity to neuromuscular blockade. Potential anesthetic modifications include regional anesthesia and avoidance of neuromuscular blockade. When neuromuscular blockade is used, careful monitoring of and titration of muscle relaxation are paramount. Myasthenic patients are at high risk of requiring postoperative ventilation. Potential emergencies specific to myasthenia gravis are myasthenic crisis and cholinergic crisis, which can be difficult to distinguish and which may require emergent invasive airway management.

Keywords

Myasthenia gravis Autoimmune disease Neuromuscular blockade Thymectomy Myasthenic crisis 

References

  1. 1.
    Baraka A. Anaesthesia and myasthenia gravis. Can J Anaesth. 1992;39:476–86.CrossRefGoogle Scholar
  2. 2.
    Hirsch NP. Neuromuscular junction in health and disease. Br J Anaesth. 2007;99:132–8.CrossRefGoogle Scholar
  3. 3.
    Dillon FX. Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol. 2004;24:83–94.CrossRefGoogle Scholar
  4. 4.
    Juel VC. Evaluation of neuromuscular junction disorders in the electromyography laboratory. Neurol Clin NA. 2012;30:621–39.CrossRefGoogle Scholar
  5. 5.
    Sanders DB, Stålberg EV. AAEM minimonograph #25: single-fiber electromyography. Muscle Nerve. 1996;19:1069–83.CrossRefGoogle Scholar
  6. 6.
    Selvan VA. Single-fiber EMG: a review. Ann Indian Acad Neurol. 2011;14:64–7.CrossRefGoogle Scholar
  7. 7.
    Hoch W, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7:365–8.CrossRefGoogle Scholar
  8. 8.
    Eisenkraft JB, Book WJ, Mann SM, Papatestas AE. Resistance to succinylcholine in myasthenia gravis: a dose-response study. Anesthesiology. 1988;69:760–2.CrossRefGoogle Scholar
  9. 9.
    Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mt Sinai J Med. 2002;69:31–7.PubMedGoogle Scholar
  10. 10.
    Smith CE, Donati F, Bevan DR. Cumulative dose-response curves for atracurium in patients with myasthenia gravis. Can J Anaesth. 1989;36:402–6.CrossRefGoogle Scholar
  11. 11.
    Eisenkraft JB, Book WJ, Papatestas AE. Sensitivity to vecuronium in myasthenia gravis: a dose-response study. Can J Anaesth. 1990;37:301–6.CrossRefGoogle Scholar
  12. 12.
    Blichfeldt-Lauridsen L, Hansen BD. Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand. 2012;56:17–22.CrossRefGoogle Scholar
  13. 13.
    Morgan JM, Barker I, Peacock JE, Eissa A. A comparison of intubating conditions in children following induction of anaesthesia with propofol and suxamethonium or propofol and remifentanil. Anaesthesia. 2007;62:135–9.CrossRefGoogle Scholar
  14. 14.
    McNeil IA, Culbert B, Russell I. Comparison of intubating conditions following propofol and succinylcholine with propofol and remifentanil 2 μg kg–1 or 4 μg kg–1. Br J Anaesth. 2000;85:623–5.CrossRefGoogle Scholar
  15. 15.
    Imani F, Alebouyeh M-R, Taghipour-Anvari Z, Faiz SH-R. Use of remifentanil and alfentanil in endotracheal intubation: a comparative study. Anesth Pain. 2011;1:1–5.CrossRefGoogle Scholar
  16. 16.
    Fotopoulou G, Theocharis S, Vasileiou I, Kouskouni E, Xanthos T. Management of the airway without the use of neuromuscular blocking agents: the use of remifentanil. Fundam Clin Pharmacol. 2011;26:72–85.CrossRefGoogle Scholar
  17. 17.
    Aouad MT, Karam VY, Mallat CE, et al. The effect of adjuvant drugs on the quality of tracheal intubation without muscle relaxants in children: a systematic review of randomized trials. Pediatr Anesth. 2012;22:616–26.CrossRefGoogle Scholar
  18. 18.
    Mikatti El N, Wilson A, Pollard BJ, Healy TE. Pulmonary function and head lift during spontaneous recovery from pipecuronium neuromuscular block. Br J Anaesth. 1995;74:16–9.CrossRefGoogle Scholar
  19. 19.
    Capron F, Fortier L-P, Racine SB, Donati FO. Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography. Anesth Analg. 2006;102:1578–84.CrossRefGoogle Scholar
  20. 20.
    Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:1–9.Google Scholar
  21. 21.
    Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II. Methods to reduce the risk of residual weakness. Anesth Analg. 2010;111:1–12.CrossRefGoogle Scholar
  22. 22.
    Murphy GS, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115:946–54.CrossRefGoogle Scholar
  23. 23.
    Todd MM, Hindman BJ, King BJ. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth Analg. 2014;119:323–31.CrossRefGoogle Scholar
  24. 24.
    Leventhal SR, Orkin FK, Hirsh RA. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology. 1980;53:26–30.CrossRefGoogle Scholar
  25. 25.
    de Perrot M, Bril V, McRae K, Keshavjee S. Impact of minimally invasive trans-cervical thymectomy on outcome in patients with myasthenia gravis. Eur J Cardiothorac Surg. 2003;24:677–83.CrossRefGoogle Scholar
  26. 26.
    Eisenkraft JB, et al. Predicting the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology. 1986;65:79–82.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Daniel J. Sisti
    • 1
  1. 1.Department of AnesthesiologyUniversity of CaliforniaSan DiegoUSA

Personalised recommendations